ARS Pharmaceuticals (SPRY) Stock Insights

SPRY price $3.65 -0.08 -2.14%

Ticker
SPRY
Price
$3.65
Change
-0.08 -2.14%
Market cap ?
$362.98M
Beta ?
0.88
Sector
Healthcare
Industry
Biotechnology

Fair value

SPRY fair value $12.04. Price $3.65. Price is 70% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 15.00M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.12% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 99.45M. Net debt 55.06M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare SPRY

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.34—41.99M
2026-08-13-0.63-0.4833.66M31.32M
2026-05-15-0.61-0.5322.68M22.20M
2026-03-09-0.42-0.4228.10M25.62M
2025-11-10-0.52-0.4532.50M25.58M
2025-08-13-0.46-0.4115.72M27.67M
2025-05-14-0.35-0.357.97M14.71M
2025-03-200.52-0.0486.58M12.84M
2024-11-13-0.20-0.182.07M17.08M
2024-08-06-0.13-0.12500.00K1.00M
2024-05-09-0.11-0.11——
2024-03-21-0.07-0.1430.00K—
2023-11-09-0.16-0.18——
2023-08-10-0.18-0.1710.00K—
2023-05-15-0.16-0.1720.00K—
2023-03-230.77-0.131.32M90.00K
2022-11-02-0.50-0.35189.00K—
2022-08-11-0.55-0.48464.00K—
2022-05-12-0.70-0.54663.00K—
2022-03-31-0.67-0.70754.00K—
2021-11-10-0.65-0.67528.00K—
2021-08-12-0.70-0.532.11M—
2021-05-13-0.54-0.352.11M—
2021-03-29-1.37-0.49——
2020-11-10-0.19———
2020-03-31-0.16———
2019-12-31-0.21———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Casale DonnBuy1.04M$4.124.27M
2026-09-01Smith Margaret EkinsBuy1.00M$5.775.78M
2026-08-17Smith Margaret EkinsOther0——
2026-07-01Casale DonnBuy898.46K$7.967.15M
2026-06-24RA CAPITAL MANAGEMENT, L.P.Buy30.00K$10.54316.20K
2026-06-24Dadoo RajeevBuy30.00K$10.54316.20K
2026-06-24Shah PratikBuy30.00K$10.54316.20K
2026-06-24Kelly MichaelBuy30.00K$10.54316.20K
2026-06-24Islam SaqibBuy30.00K$10.54316.20K
2026-06-24Thompson Peter A.Buy30.00K$10.54316.20K
2026-06-24SAUNDERS BRENT LBuy30.00K$10.54316.20K
2026-06-24SCHNEIDER PHILLIP MBuy30.00K$10.54316.20K
2026-06-24Shawver LauraBuy30.00K$10.54316.20K
2026-06-12Karas EricSell25.00K$1.5037.50K
2026-06-12Karas EricBuy25.00K$1.5037.50K
2026-06-12Karas EricSell25.00K$10.00250.00K
2026-06-12Fitzpatrick Alexander ASell3.35K$10.0033.55K
2026-06-01Casale DonnOther0——
2026-01-02Scott Kathleen D.Buy240.00K$11.492.76M
2026-01-02Karas EricBuy240.00K$11.492.76M
2026-01-02Fitzpatrick Alexander ABuy240.00K$11.492.76M
2026-01-02Dorsey BrianBuy240.00K$11.492.76M
2026-01-02Chakma JustinBuy240.00K$11.492.76M
2026-01-02Tanimoto SarinaBuy875.00K$11.4910.05M
2026-01-02Tanimoto SarinaBuy240.00K$11.492.76M
2026-01-02Lowenthal Richard EBuy875.00K$11.4910.05M
2026-01-02Lowenthal Richard EBuy240.00K$11.492.76M
2025-11-13Dorsey BrianBuy21.83K$0.6413.97K
2025-11-13Dorsey BrianSell21.83K$8.71190.05K
2025-11-13Dorsey BrianSell21.83K$0.6413.97K
2025-11-12Chakma JustinBuy30.00K$0.8425.20K
2025-11-12Chakma JustinSell30.00K$8.91267.36K
2025-11-12Chakma JustinSell30.00K$0.8425.20K
2025-11-12Chakma JustinSell136.38K$8.861.21M
2025-11-12Shah PratikSell250.00K——
2025-11-12Shah PratikSell100.00K——
2025-08-21Lowenthal Richard ESell50.00K$14.49724.35K
2025-08-21Scott Kathleen D.Sell12.50K$1.5018.75K
2025-08-21Scott Kathleen D.Buy12.50K$1.5018.75K
2025-08-21Scott Kathleen D.Sell12.50K$15.00187.50K
2025-08-20Tanimoto SarinaSell37.66K$14.09530.63K
2025-08-19Tanimoto SarinaSell12.34K$14.03173.13K
2025-07-01Karas EricSell15.00K$1.5022.50K
2025-07-01Karas EricBuy15.00K$1.5022.50K
2025-07-01Karas EricSell15.00K$16.99254.86K
2025-06-27Flynn James ESell370.07K$18.466.83M
2025-06-25RA CAPITAL MANAGEMENT, L.P.Buy30.00K$17.26517.80K
2025-06-25Dadoo RajeevBuy30.00K$17.26517.80K
2025-06-25Shah PratikBuy30.00K$17.26517.80K
2025-06-25Kelly MichaelBuy30.00K$17.26517.80K
2025-06-25Islam SaqibBuy30.00K$17.26517.80K
2025-06-25Thompson Peter A.Buy30.00K$17.26517.80K
2025-06-25SAUNDERS BRENT LBuy30.00K$17.26517.80K
2025-06-25SCHNEIDER PHILLIP MBuy30.00K$17.26517.80K
2025-06-25Shawver LauraBuy30.00K$17.26517.80K
2025-06-18Karas EricSell15.00K$1.5022.50K
2025-06-18Karas EricBuy15.00K$1.5022.50K
2025-06-18Karas EricSell15.00K$16.00240.00K
2025-05-20Fitzpatrick Alexander ASell100.00K$5.58558.00K
2025-05-20Fitzpatrick Alexander ABuy100.00K$5.58558.00K
2025-05-20Fitzpatrick Alexander ASell102.97K$14.101.45M
2025-05-20SAUNDERS BRENT LSell120.00K$1.01121.20K
2025-05-20SAUNDERS BRENT LBuy120.00K$1.01121.20K
2025-05-20SAUNDERS BRENT LSell120.00K$14.251.71M
2025-05-20Scott Kathleen D.Sell50.00K$1.5075.00K
2025-05-20Scott Kathleen D.Buy50.00K$1.5075.00K
2025-05-20Scott Kathleen D.Sell50.00K$14.10705.16K
2025-04-07Shawver LauraBuy27.49K$4.85133.34K
2025-04-07Shawver LauraBuy22.51K$4.85109.17K
2025-04-07Shawver LauraSell50.00K$12.30615.07K
2025-04-07Shawver LauraSell22.51K$4.85109.17K
2025-04-07Shawver LauraSell27.49K$4.85133.34K
2025-03-20Karas EricSell10.00K$1.5015.00K
2025-03-20Karas EricBuy10.00K$1.5015.00K
2025-03-20Karas EricSell10.00K$14.00140.00K
2025-03-06Shawver LauraBuy49.60K$4.85240.56K
2025-03-06Shawver LauraSell49.60K$11.21556.05K
2025-03-06Shawver LauraSell49.60K$4.85240.56K
2025-03-05Shawver LauraBuy400$4.851.94K
2025-03-05Shawver LauraSell400$11.004.40K
2025-03-05Shawver LauraSell400$4.851.94K
2025-02-03Shawver LauraBuy40.94K$4.85198.54K
2025-02-03Shawver LauraBuy9.06K$3.1528.55K
2025-02-03Shawver LauraSell50.00K$12.31615.57K
2025-02-03Shawver LauraSell40.94K$4.85198.54K
2025-02-03Shawver LauraSell9.06K$3.1528.55K
2025-01-06Shawver LauraBuy50.00K$3.15157.50K
2025-01-06Shawver LauraSell50.00K$11.10555.07K
2025-01-06Shawver LauraSell50.00K$3.15157.50K
2025-01-02Fitzpatrick Alexander ABuy152.30K$10.711.63M
2025-01-02Dorsey BrianBuy261.90K$10.712.80M
2025-01-02Tanimoto SarinaBuy767.60K$10.718.22M
2025-01-02Tanimoto SarinaBuy261.90K$10.712.80M
2025-01-02Lowenthal Richard EBuy767.60K$10.718.22M
2025-01-02Lowenthal Richard EBuy261.90K$10.712.80M
2025-01-02Chakma JustinBuy274.10K$10.712.94M
2025-01-02Scott Kathleen D.Buy176.70K$10.711.89M
2025-01-02Karas EricBuy152.30K$10.711.63M
2024-12-17Tanimoto SarinaSell50.00K$11.67583.58K
2024-12-17Tanimoto SarinaSell50.00K$11.67583.52K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 217, holders +10 vs prior quarter. Ownership 91.81%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.10.86M00.00%87.00M
RUBRIC CAPITAL MANAGEMENT LP8.54M540.86K+6.76%68.41M
ORBIMED ADVISORS LLC8.29M00.00%66.39M
DEERFIELD MANAGEMENT COMPANY, L.P.7.50M00.00%60.11M
BLACKROCK, INC.5.31M299.06K+5.97%42.54M
TYRO CAPITAL MANAGEMENT LLC4.46M1.49M+50.22%35.72M
ABERDEEN GROUP PLC4.17M57.01K+1.39%33.41M
SR ONE CAPITAL MANAGEMENT, LP4.01M00.00%32.14M
STATE STREET CORP3.73M85.66K+2.35%29.88M
CAPITAL WORLD INVESTORS2.75M2.75MNew22.07M
VANGUARD CAPITAL MANAGEMENT LLC2.55M11.02K+0.43%20.45M
MILLENNIUM MANAGEMENT LLC2.40M-3.58M-59.87%19.23M
JANNEY MONTGOMERY SCOTT LLC2.06M48.03K+2.38%16.54M
UBS GROUP AG1.94M-320.67K-14.19%15.54M
GEODE CAPITAL MANAGEMENT, LLC1.70M172.19K+11.28%13.61M
BOOTHBAY FUND MANAGEMENT, LLC1.60M1.35M+539.08%12.83M
GENERAL AMERICAN INVESTORS CO INC1.13M405.89K+55.82%9.08M
THIRD POINT LLC1.00M00.00%8.01M
PEREGRINE CAPITAL MANAGEMENT LLC672.14K672.14KNew5.38M
TEJARA CAPITAL LTD607.04K396.64K+188.52%4.86M
ADAR1 CAPITAL MANAGEMENT, LLC601.00K-760.54K-55.86%4.81M
PAVAKI CAPITAL MANAGEMENT LLC579.60K3.40K+0.59%4.64M
VANGUARD PORTFOLIO MANAGEMENT LLC566.83K56.28K+11.02%4.54M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.551.42K551.42KNew4.42M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC551.42K18.02K+3.38%4.42M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

ARS Pharmaceuticals (SPRY) Stock Insights

SPRY$3.65-0.08 -2.14%

$362.98M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History